Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Treated With Alemtuzumab”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Testing effectiveness (Phase 2)Ended earlyNCT00262925
What this trial is testing

Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent Adult Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)WithdrawnNCT00226512
What this trial is testing

To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Hadassah Medical Organization 203
Testing effectiveness (Phase 2)Study completedNCT00065260
What this trial is testing

Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 54
Testing effectiveness (Phase 2)Study completedNCT04312841
What this trial is testing

Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

Who this might be right for
B-Cell Prolymphocytic LeukemiaChronic Lymphocytic LeukemiaPeripheral T-Cell Lymphoma+3 more
Ohio State University Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00195624
What this trial is testing

Alemtuzumab to Treat Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia, RefractorySevere Aplastic Anemia, Relapse
National Heart, Lung, and Blood Institute (NHLBI) 47
Testing effectiveness (Phase 2)Study completedNCT00098670
What this trial is testing

Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic Leukemia+2 more
National Cancer Institute (NCI) 102
Not applicableStudy completedNCT01315457
What this trial is testing

Infections Associated With the Use of Alemtuzumab

Who this might be right for
Patients Treated With Alemtuzumab
Samsung Medical Center 182
Not applicableEnded earlyNCT00836043
What this trial is testing

Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Genzyme, a Sanofi Company 6
Testing effectiveness (Phase 2)Study completedNCT00553098
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders

Who this might be right for
Immunodeficiency SyndromeNon-Cancer Diagnosis
Fred Hutchinson Cancer Center 29
Testing effectiveness (Phase 2)UnknownNCT00907036
What this trial is testing

Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma

Who this might be right for
Lymphoma
Cancer Research UK 49
Testing effectiveness (Phase 2)Study completedNCT00079768
What this trial is testing

Alemtuzumab to Treat Sporadic Inclusion Body Myositis

Who this might be right for
Myositis, Inclusion Body
National Institute of Neurological Disorders and Stroke (NINDS) 20
Testing effectiveness (Phase 2)Study completedNCT00930605
What this trial is testing

The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-cell Lymphoma
King Chulalongkorn Memorial Hospital 16
Large-scale testing (Phase 3)Study completedNCT00530348
What this trial is testing

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genzyme, a Sanofi Company 581
Testing effectiveness (Phase 2)Study completedNCT00118352
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+61 more
Fred Hutchinson Cancer Center 12
Not applicableWithdrawnNCT01639573
What this trial is testing

Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for Refractory Systemic Sclerosis

Who this might be right for
Scleroderma
Children's Hospital Los Angeles
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00004857
What this trial is testing

Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 86
Not applicableStudy completedNCT00073879
What this trial is testing

Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Kidney Cancer
Baylor College of Medicine
Testing effectiveness (Phase 2)Study completedNCT00193466
What this trial is testing

Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
SCRI Development Innovations, LLC 40
Testing effectiveness (Phase 2)Ended earlyNCT01875237
What this trial is testing

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

Who this might be right for
LeukemiaMyelomaMyeloproliferative Diseases
M.D. Anderson Cancer Center 3
Next Page